BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16785538)

  • 21. Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1.
    Shi S; Blumenthal A; Hickey CM; Gandotra S; Levy D; Ehrt S
    J Immunol; 2005 Sep; 175(5):3318-28. PubMed ID: 16116224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacterium tuberculosis lipoprotein-induced association of TLR2 with protein kinase C zeta in lipid rafts contributes to reactive oxygen species-dependent inflammatory signalling in macrophages.
    Shin DM; Yang CS; Lee JY; Lee SJ; Choi HH; Lee HM; Yuk JM; Harding CV; Jo EK
    Cell Microbiol; 2008 Sep; 10(9):1893-905. PubMed ID: 18503635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.
    Lancioni CL; Li Q; Thomas JJ; Ding X; Thiel B; Drage MG; Pecora ND; Ziady AG; Shank S; Harding CV; Boom WH; Rojas RE
    Infect Immun; 2011 Feb; 79(2):663-73. PubMed ID: 21078852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria.
    Neyrolles O; Gould K; Gares MP; Brett S; Janssen R; O'Gaora P; Herrmann JL; Prévost MC; Perret E; Thole JE; Young D
    J Immunol; 2001 Jan; 166(1):447-57. PubMed ID: 11123323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR2 is non-redundant in the population and subpopulation responses to
    Jani C; Solomon SL; Peters JM; Pringle SC; Hinman AE; Boucau J; Bryson BD; Barczak AK
    mSystems; 2023 Aug; 8(4):e0005223. PubMed ID: 37439558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.
    Gehring AJ; Rojas RE; Canaday DH; Lakey DL; Harding CV; Boom WH
    Infect Immun; 2003 Aug; 71(8):4487-97. PubMed ID: 12874328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins.
    Blumenthal A; Kobayashi T; Pierini LM; Banaei N; Ernst JD; Miyake K; Ehrt S
    Cell Host Microbe; 2009 Jan; 5(1):35-46. PubMed ID: 19154986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses.
    Revets H; Pynaert G; Grooten J; De Baetselier P
    J Immunol; 2005 Jan; 174(2):1097-103. PubMed ID: 15634935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium tuberculosis PPE51 Inhibits Autophagy by Suppressing Toll-Like Receptor 2-Dependent Signaling.
    Strong EJ; Wang J; Ng TW; Porcelli SA; Lee S
    mBio; 2022 Jun; 13(3):e0297421. PubMed ID: 35467412
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Padhi A; Pattnaik K; Biswas M; Jagadeb M; Behera A; Sonawane A
    J Immunol; 2019 Nov; 203(10):2665-2678. PubMed ID: 31619537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression.
    Yang CS; Shin DM; Kim KH; Lee ZW; Lee CH; Park SG; Bae YS; Jo EK
    J Immunol; 2009 Mar; 182(6):3696-705. PubMed ID: 19265148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages.
    Rocha-Ramírez LM; Estrada-García I; López-Marín LM; Segura-Salinas E; Méndez-Aragón P; Van Soolingen D; Torres-González R; Chacón-Salinas R; Estrada-Parra S; Maldonado-Bernal C; López-Macías C; Isibasi A
    Tuberculosis (Edinb); 2008 May; 88(3):212-20. PubMed ID: 18222732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the question.
    Gopalakrishnan A; Salgame P
    Curr Opin Immunol; 2016 Oct; 42():76-82. PubMed ID: 27326654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Codominance of TLR2-dependent and TLR2-independent modulation of MHC class II in Mycobacterium tuberculosis infection in vivo.
    Kincaid EZ; Wolf AJ; Desvignes L; Mahapatra S; Crick DC; Brennan PJ; Pavelka MS; Ernst JD
    J Immunol; 2007 Sep; 179(5):3187-95. PubMed ID: 17709534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
    Means TK; Jones BW; Schromm AB; Shurtleff BA; Smith JA; Keane J; Golenbock DT; Vogel SN; Fenton MJ
    J Immunol; 2001 Mar; 166(6):4074-82. PubMed ID: 11238656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Navigating through the maze of TLR2 mediated signaling network for better mycobacterium infection control.
    Yu X; Zeng J; Xie J
    Biochimie; 2014 Jul; 102():1-8. PubMed ID: 24594065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors.
    Harding CV; Boom WH
    Nat Rev Microbiol; 2010 Apr; 8(4):296-307. PubMed ID: 20234378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma.
    Nagabhushanam V; Solache A; Ting LM; Escaron CJ; Zhang JY; Ernst JD
    J Immunol; 2003 Nov; 171(9):4750-7. PubMed ID: 14568951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterium tuberculosis Rv0577, a novel TLR2 agonist, induces maturation of dendritic cells and drives Th1 immune response.
    Byun EH; Kim WS; Kim JS; Jung ID; Park YM; Kim HJ; Cho SN; Shin SJ
    FASEB J; 2012 Jun; 26(6):2695-711. PubMed ID: 22415304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.
    Bafica A; Scanga CA; Feng CG; Leifer C; Cheever A; Sher A
    J Exp Med; 2005 Dec; 202(12):1715-24. PubMed ID: 16365150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.